Brain Edema, Imaging Abnormalities Reported for Alzheimer’s Drug

(MedPage Today) — Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early symptomatic Alzheimer’s disease, a secondary analysis of trial data showed.
In phase II and III trials of…